TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
OKUR

OnKure Therapeutics, Inc.

Healthcare · Biotechnology

3.00$ +2.8% vs. previous close Closing price · As of: Sep 17, 2026

Ownership

Ownership Structure

Who owns OnKure Therapeutics, Inc. (OKUR)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 52.8% of the shares are freely tradable; institutional investors hold 76.1%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 76.1%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 10.5%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 52.8%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 3.6%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 41Mio.

Largest Shareholders

Institutions

Institutions OKUR
Name Stake (%) Shares Change (%) Date
RA Capital Management, LLC 9.87 3,998,333 +0.0 03/31/2026
StepStone Group LLC 6.57 2,660,612 +440.8 03/31/2026
ADAR1 Capital Management LLC 6.01 2,434,941 +140.1 03/31/2026
Bvf Inc 4.89 1,978,972 +0.0 03/31/2026
Vivo Capital, LLC 4.76 1,927,710 +0.0 06/30/2026
Vestal Point Capital LP 4.54 1,839,819 +189.7 03/31/2026
Trails Edge Capital Partners, LP 3.55 1,438,456 +0.0 06/30/2026
Adage Capital Partners Gp LLC 2.98 1,204,819 +0.0 06/30/2026
Citadel Advisors Llc 2.93 1,187,047 +3,058.1 06/30/2026

Funds

Funds OKUR
Name Stake (%) Shares Change (%) Date
Vanguard MStar Total Stk Mkt Idx Invest 2.85 1,154,070 +4.0 07/31/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?